Center for Health Outcomes Research, McGill University, 5252 de Maisonneuve West, #3D-57, Montreal, QC, H4A 3S5, Canada.
Division of Rheumatology, Johns Hopkins School of Medicine, Mason F Lord Tower, 5200 Eastern Avenue, Rm 404, Baltimore, MD, 21224, USA.
Qual Life Res. 2018 Sep;27(9):2443-2451. doi: 10.1007/s11136-018-1880-x. Epub 2018 May 24.
Fatigue is frequent and often severe and disabling in RA, and there is no consensus on how to measure it. We used online surveys and in-person interviews to evaluate PROMIS Fatigue 7a and 8a short forms (SFs) in people with RA.
We recruited people with RA from an online patient community (n = 200) and three academic medical centers (n = 84) in the US. Participants completed both SFs then rated the comprehensiveness and comprehensibility of the items to their fatigue experience. Cognitive debriefing of items was conducted in a subset of 32 clinic patients. Descriptive statistics were calculated, and associations were evaluated using Pearson and Spearman correlation coefficients.
Mean SF scores were similar (p ≥ .61) among clinic patients reflecting mild fatigue (i.e., 54.5-55.9), but were significantly higher (p < .001) in online participants. SF Fatigue scores correlated highly (r ≥ 0.82; p < .000) and moderately with patient assessments of disease activity (r ≥ 0.62; p = .000). Most (70-92%) reported that the items "completely" or "mostly" reflected their experience. Almost all (≥ 94%) could distinguish general fatigue from RA fatigue. Most (≥ 85%) rated individual items questions as "somewhat" or "very relevant" to their fatigue experience, averaged their fatigue over the past 7 days (58%), and rated fatigue impact versus severity (72 vs. 19%). 99% rated fatigue as an important symptom they considered when deciding how well their current treatment was controlling their RA.
Results suggest that items in the single-score PROMIS Fatigue SFs demonstrate content validity and can adequately capture the wide range of fatigue experiences of people with RA.
疲劳在 RA 中很常见,且通常较为严重并导致残疾,但目前尚无衡量疲劳的共识。我们使用在线调查和面对面访谈评估了 RA 患者的 PROMIS 疲劳 7a 和 8a 短式量表(SF)。
我们在美国的一个在线患者社区(n=200)和三个学术医疗中心(n=84)招募了 RA 患者。参与者完成了两个 SF 量表,然后对项目与他们的疲劳体验的全面性和可理解性进行了评分。对 32 名门诊患者进行了项目认知性审阅。计算了描述性统计数据,并使用 Pearson 和 Spearman 相关系数评估了相关性。
反映轻度疲劳(即 54.5-55.9)的门诊患者的 SF 量表得分相似(p≥.61),但在线参与者的得分显著更高(p<.001)。SF 量表疲劳评分与患者对疾病活动的评估高度相关(r≥0.82;p<.000),中度相关(r≥0.62;p=0.000)。大多数(70-92%)报告说,这些项目“完全”或“主要”反映了他们的体验。几乎所有人(≥94%)都能将一般疲劳与 RA 疲劳区分开来。大多数(≥85%)对单个项目问题的评价为“有些”或“非常相关”,对过去 7 天的疲劳进行了平均(58%),并对疲劳的影响与严重程度进行了评分(72 对 19%)。99%的患者认为疲劳是他们在决定当前治疗是否控制 RA 时考虑的重要症状。
结果表明,单一评分 PROMIS 疲劳 SF 量表中的项目具有内容有效性,能够充分捕捉 RA 患者的广泛疲劳体验。